Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cipla
Citi
Healthtrust
Mallinckrodt
Harvard Business School
Cerilliant
Chinese Patent Office
US Army

Generated: April 20, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lenvatinib mesylate

« Back to Dashboard

lenvatinib mesylate

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc LENVIMA lenvatinib mesylate CAPSULE;ORAL 206947 NDA Eisai Inc. N 62856-708-30
Eisai Inc LENVIMA lenvatinib mesylate CAPSULE;ORAL 206947 NDA Eisai Inc. N 62856-710-30
Eisai Inc LENVIMA lenvatinib mesylate CAPSULE;ORAL 206947 NDA Eisai Inc. N 62856-714-30
Eisai Inc LENVIMA lenvatinib mesylate CAPSULE;ORAL 206947 NDA Eisai Inc. N 62856-718-30
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Argus Health
Healthtrust
Boehringer Ingelheim
Dow
Daiichi Sankyo
Farmers Insurance
Accenture